Search results for "Prostate cancer"
New research evaluates strategies for prostate cancer screening
Prostate-specific antigen (PSA) screening reduced mortality over the long term, magnetic resonance imaging (MRI) and targeted biopsies improved early detection, and a multistep screening protocol involving a PSA test, a 4-kallikrein panel, and an MRI showed promise.
https://immattersacp.org/weekly/archives/2024/04/09/2.htm
9 Apr 2024
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Decision support intervention for clinicians helped decrease low-value care
A tool to increase clinicians' attention to the possible harms of overtreatment among older adults, among other aims, was associated with a greater decline in prostate-specific antigen testing, unspecified urine testing, and diabetes overtreatment compared with an education-only approach.
https://immattersacp.org/weekly/archives/2024/02/06/4.htm
6 Feb 2024
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Digital rectal exam may be ineffective for prostate cancer screening, meta-analysis indicates
The authors recommended against routine screening with this method in primary care to minimize unnecessary diagnostic testing, overdiagnosis, and overtreatment.
https://immattersacp.org/weekly/archives/2018/03/20/2.htm
20 Mar 2018
Playing the blame game for rising prostate cancer rates
Blame the rising rate of prostate cancer on better testing. Blame it on the ubiquity of the disease as men age. Just don't blame it on the pathologists. They feel bad enough.
https://immattersacp.org/archives/2008/07/prostate.htm
1 Jul 2008
No overall association seen between postdiagnosis low-dose aspirin, prostate cancer mortality
Data were collected from a nationwide Danish registry on tumor characteristics, drug use, primary prostate cancer therapy, comorbid conditions, and socioeconomic variables for men with incident prostate adenocarcinoma between 2000 and 2011.
https://immattersacp.org/weekly/archives/2019/03/05/1.htm
5 Mar 2019
Be on alert for blood cancer precursors
Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
https://immattersacp.org/archives/2023/07/be-on-alert-for-blood-cancer-precursors.htm
1 Jul 2023
Study compares after-effects of prostatectomy, active surveillance, radiation, hormone therapy for prostate cancer
Estimates of long-term bowel, bladder, and sexual function after localized prostate cancer treatment may enable men to make informed choices about care, the authors said.
https://immattersacp.org/weekly/archives/2020/01/28/4.htm
28 Jan 2020
Make screening for prostate cancer an individual choice, USPSTF says
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
https://immattersacp.org/weekly/archives/2018/05/15/1.htm
15 May 2018